1. Home
  2. OCSL vs RVPHW Comparison

OCSL vs RVPHW Comparison

Compare OCSL & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • RVPHW
  • Stock Information
  • Founded
  • OCSL 2007
  • RVPHW 2018
  • Country
  • OCSL United States
  • RVPHW United States
  • Employees
  • OCSL N/A
  • RVPHW 14
  • Industry
  • OCSL Finance: Consumer Services
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCSL Finance
  • RVPHW Health Care
  • Exchange
  • OCSL Nasdaq
  • RVPHW Nasdaq
  • Market Cap
  • OCSL 1.2B
  • RVPHW N/A
  • IPO Year
  • OCSL 2008
  • RVPHW N/A
  • Fundamental
  • Price
  • OCSL $13.79
  • RVPHW $0.06
  • Analyst Decision
  • OCSL Hold
  • RVPHW
  • Analyst Count
  • OCSL 6
  • RVPHW 0
  • Target Price
  • OCSL $15.20
  • RVPHW N/A
  • AVG Volume (30 Days)
  • OCSL 466.5K
  • RVPHW 22.4K
  • Earning Date
  • OCSL 08-05-2025
  • RVPHW 03-14-2025
  • Dividend Yield
  • OCSL 11.60%
  • RVPHW N/A
  • EPS Growth
  • OCSL N/A
  • RVPHW N/A
  • EPS
  • OCSL 0.55
  • RVPHW N/A
  • Revenue
  • OCSL $334,099,000.00
  • RVPHW N/A
  • Revenue This Year
  • OCSL N/A
  • RVPHW N/A
  • Revenue Next Year
  • OCSL N/A
  • RVPHW N/A
  • P/E Ratio
  • OCSL $25.23
  • RVPHW N/A
  • Revenue Growth
  • OCSL N/A
  • RVPHW N/A
  • 52 Week Low
  • OCSL $12.50
  • RVPHW $0.13
  • 52 Week High
  • OCSL $16.66
  • RVPHW $0.15
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 48.68
  • RVPHW N/A
  • Support Level
  • OCSL $13.70
  • RVPHW N/A
  • Resistance Level
  • OCSL $14.03
  • RVPHW N/A
  • Average True Range (ATR)
  • OCSL 0.17
  • RVPHW 0.00
  • MACD
  • OCSL 0.00
  • RVPHW 0.00
  • Stochastic Oscillator
  • OCSL 44.44
  • RVPHW 0.00

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: